Merus N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRUS research report →
About the company
Merus N. V. is a clinical-stage immuno-oncology firm based in the Netherlands, specializing in the discovery and advancement of bispecific antibody therapies.
- CEO
- Jan van de Winkel
- IPO
- 2016
- Employees
- 260
- HQ
- Utrecht, NL
Price Chart
Get TickerSpark's AI analysis on MRUS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $6.83B
- P/E
- -18.40
- P/S
- 154.68
- P/B
- 10.29
- EV/EBITDA
- -27.33
- Div Yield
- 0.00%
- Gross Margin
- -249.98%
- Op Margin
- -589.59%
- Net Margin
- -722.94%
- ROE
- -45.59%
- ROIC
- -37.15%
- Revenue
- $34.88M · -12.38%
- Net Income
- $-207,854,187 · -48.10%
- EPS
- $-3.35 · -11.67%
- Op Income
- $-262,626,275
- FCF YoY
- -28.26%
- 52W High
- $97.14
- 52W Low
- $33.19
- 50D MA
- $95.61
- 200D MA
- $68.01
- Beta
- 1.06
- Avg Volume
- 1.72M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 29, 25 | GENMAB A/S | buy | 1,052,806 |
| Dec 26, 25 | GENMAB A/S | buy | 2,978 |
| Dec 29, 25 | GENMAB A/S | buy | 75,867,199 |
| Dec 26, 25 | GENMAB A/S | buy | 142,610 |
| Dec 24, 25 | GENMAB A/S | buy | 96,082 |
| Dec 23, 25 | GENMAB A/S | buy | 561,042 |
| Dec 22, 25 | GENMAB A/S | buy | 15,710 |
| Dec 19, 25 | GENMAB A/S | buy | 66,264 |
| Dec 18, 25 | GENMAB A/S | buy | 212,177 |
| Dec 17, 25 | GENMAB A/S | buy | 150,795 |
Our MRUS coverage
Recent articles, reports, and earnings notes.
Want a deeper read on MRUS?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.
LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com · May 7
Merus Power Delivers an Energy Storage System for Extreme Arctic Conditions
businesswire.com · Feb 11
Federated Hermes Inc. Sells 279,425 Shares of Merus N.V. $MRUS
defenseworld.net · Jan 29
Merus N.V. (NASDAQ:MRUS) Receives Average Recommendation of “Hold” from Analysts
defenseworld.net · Jan 7
Market Today: Tesla dethroned; Wall St. starts 2026 higher
gurufocus.com · Jan 2
First Look: Futures Climb, FTSE 10,000, BYD Tops Tesla
gurufocus.com · Jan 2
First Look: 2026 Outlook, Buffett Exit, Fed Split, Dollar Slide
gurufocus.com · Jan 1
A/S Genmab Buys 2,978 Shares of Merus (NASDAQ:MRUS) Stock
defenseworld.net · Jan 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
Community Sentiment
Be the first to call it — is MRUS a buy or a sell from here?